vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and ENANTA PHARMACEUTICALS INC (ENTA). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $18.6M, roughly 1.8× ENANTA PHARMACEUTICALS INC). Clearfield, Inc. runs the higher net margin — -1.8% vs -64.1%, a 62.3% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -3.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
CLFD vs ENTA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $18.6M |
| Net Profit | $-614.0K | $-11.9M |
| Gross Margin | 33.2% | — |
| Operating Margin | -5.3% | -60.5% |
| Net Margin | -1.8% | -64.1% |
| Revenue YoY | -3.2% | 9.8% |
| Net Profit YoY | 67.8% | 46.4% |
| EPS (diluted) | $-0.04 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $18.6M | ||
| Q3 25 | $23.4M | $15.1M | ||
| Q2 25 | $49.9M | $18.3M | ||
| Q1 25 | $47.2M | $14.9M | ||
| Q4 24 | $29.7M | $17.0M | ||
| Q3 24 | $5.6M | $14.6M | ||
| Q2 24 | $48.8M | $18.0M | ||
| Q1 24 | $36.9M | $17.1M |
| Q4 25 | $-614.0K | $-11.9M | ||
| Q3 25 | $-9.1M | $-18.7M | ||
| Q2 25 | $1.6M | $-18.3M | ||
| Q1 25 | $1.3M | $-22.6M | ||
| Q4 24 | $-1.9M | $-22.3M | ||
| Q3 24 | — | $-28.8M | ||
| Q2 24 | $-447.0K | $-22.7M | ||
| Q1 24 | $-5.9M | $-31.2M |
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | -5.3% | -60.5% | ||
| Q3 25 | 10.3% | -121.6% | ||
| Q2 25 | 3.0% | -103.2% | ||
| Q1 25 | 0.6% | -164.3% | ||
| Q4 24 | -6.9% | -138.8% | ||
| Q3 24 | — | -204.4% | ||
| Q2 24 | -4.7% | -134.6% | ||
| Q1 24 | -26.4% | -192.1% |
| Q4 25 | -1.8% | -64.1% | ||
| Q3 25 | -38.8% | -123.6% | ||
| Q2 25 | 3.2% | -99.7% | ||
| Q1 25 | 2.8% | -151.7% | ||
| Q4 24 | -6.4% | -131.4% | ||
| Q3 24 | — | -197.3% | ||
| Q2 24 | -0.9% | -126.1% | ||
| Q1 24 | -16.0% | -182.7% |
| Q4 25 | $-0.04 | $-0.42 | ||
| Q3 25 | $-0.65 | $-0.88 | ||
| Q2 25 | $0.11 | $-0.85 | ||
| Q1 25 | $0.09 | $-1.06 | ||
| Q4 24 | $-0.13 | $-1.05 | ||
| Q3 24 | — | $-1.36 | ||
| Q2 24 | $-0.04 | $-1.07 | ||
| Q1 24 | $-0.40 | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $37.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $126.6M |
| Total Assets | $268.1M | $329.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $37.4M | ||
| Q3 25 | $106.0M | $32.3M | ||
| Q2 25 | $117.2M | $44.8M | ||
| Q1 25 | $112.0M | $60.2M | ||
| Q4 24 | $113.0M | $84.3M | ||
| Q3 24 | $129.0M | $37.2M | ||
| Q2 24 | $123.8M | $35.8M | ||
| Q1 24 | $142.9M | $63.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $126.6M | ||
| Q3 25 | $256.2M | $64.7M | ||
| Q2 25 | $264.5M | $79.3M | ||
| Q1 25 | $265.9M | $93.5M | ||
| Q4 24 | $267.4M | $111.8M | ||
| Q3 24 | $275.8M | $128.8M | ||
| Q2 24 | $274.6M | $148.9M | ||
| Q1 24 | $279.2M | $166.1M |
| Q4 25 | $268.1M | $329.5M | ||
| Q3 25 | $306.2M | $280.7M | ||
| Q2 25 | $314.7M | $301.0M | ||
| Q1 25 | $310.9M | $323.0M | ||
| Q4 24 | $303.2M | $348.6M | ||
| Q3 24 | $315.3M | $376.7M | ||
| Q2 24 | $318.1M | $398.8M | ||
| Q1 24 | $315.4M | $413.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-11.7M |
| Free Cash FlowOCF − Capex | $-2.4M | $-11.8M |
| FCF MarginFCF / Revenue | -7.1% | -63.6% |
| Capex IntensityCapex / Revenue | 2.9% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-18.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-11.7M | ||
| Q3 25 | — | $-6.5M | ||
| Q2 25 | $7.9M | $17.5M | ||
| Q1 25 | $3.0M | $-13.5M | ||
| Q4 24 | $7.2M | $-16.8M | ||
| Q3 24 | $22.2M | $-10.4M | ||
| Q2 24 | $4.0M | $-14.8M | ||
| Q1 24 | $-5.7M | $-28.6M |
| Q4 25 | $-2.4M | $-11.8M | ||
| Q3 25 | — | $-7.9M | ||
| Q2 25 | $7.5M | $17.4M | ||
| Q1 25 | $654.0K | $-16.0M | ||
| Q4 24 | $5.1M | $-25.5M | ||
| Q3 24 | $18.2M | $-19.4M | ||
| Q2 24 | $2.8M | $-21.3M | ||
| Q1 24 | $-7.7M | $-30.3M |
| Q4 25 | -7.1% | -63.6% | ||
| Q3 25 | — | -52.5% | ||
| Q2 25 | 15.1% | 94.7% | ||
| Q1 25 | 1.4% | -107.4% | ||
| Q4 24 | 17.1% | -150.6% | ||
| Q3 24 | 323.0% | -132.5% | ||
| Q2 24 | 5.8% | -118.6% | ||
| Q1 24 | -20.8% | -177.5% |
| Q4 25 | 2.9% | 0.8% | ||
| Q3 25 | 2.0% | 9.6% | ||
| Q2 25 | 0.8% | 0.8% | ||
| Q1 25 | 5.1% | 17.0% | ||
| Q4 24 | 7.0% | 51.6% | ||
| Q3 24 | 71.4% | 61.3% | ||
| Q2 24 | 2.5% | 36.4% | ||
| Q1 24 | 5.3% | 9.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
